Navigation Links
Next-Generation Hemostatic Dressing Available for Military Emergencies

HemCon offers revolutionary, easy to use Z-Folded design with antibacterial effectiveness.

Portland, OR (Vocus) July 21, 2009 -- HemCon Medical Technologies, Inc., today announced the launch of the ChitoGauze™ dressing platform. ChitoGauze is a next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care use and is proven effective on severe, arterial bleeding. The initial product design received FDA 510(k) clearance in April 2009 and is available immediately for the military medical market in a 4 inch by 4 yard flexible and conforming gauze dressing.

From the creators of the hemostatic HemCon® Bandages, saving lives on the battlefield since 2003, comes a uniquely formulated chitosan impregnated gauze dressing. Designed to offer the latest in battlefield care requirements, this hemostatic dressing is formed in a unique z-folded pleat making delivery from package to wound easier and quicker than with a rolled product. "The dynamic stresses of combat operations can create an environment that is often overwhelming for battlefield care providers. A product that is not only highly effective, but is also easily employed is paramount. A simple modification such as making your package easy to open, or a z-folded dressing rather than rolled, can save a medic precious time which translates to saving lives," said former U.S. Army Medic Christopher Murphy, now of Wake Forest University. HemCon states that in addition to the z-fold, the dressing will ship by Fall 2009 with a packaging configuration that can be opened from any angle to offer easier, more rapid and sterile deployment. "Over our long and strong relationship with the U.S. Army, HemCon has teamed with military medical professionals to understand the latest field requirements and deliver what is needed. It's our mission to continue to help keep our soldiers coming home. Through the launch of the ChitoGauze platform, we're able to provide a critical, safe dressing that saves lives," said Bill Block, President of HemCon, U.S. and former U.S. Army Ranger.

The unique formulation of hemostatic ChitoGauze also offers antibacterial properties which provide medical professionals a multi-layered solution to help avoid infection. "As a physician, there's a great deal to consider when treating a wound - whether you are on the battlefield or in the ER. Having an antibacterial, protective layer provides an element of defense I want my patients to have," said Sudip Bose, MD, FACEP, FAAEM, attending Emergency Physician and former Major, U.S. Army. In testing, ChitoGauze demonstrated antibacterial properties against a wide range of microorganisms, including MRSA, VRE and Acinetobacter Baumannii.

HemCon's proprietary manufacturing process and the natural, unique characteristics of chitosan together create the ChitoGauze mechanism of action which slows blood movement through the dressing, offering a local hemostatic solution. The chitosan in ChitoGauze, without the addition of pro-clotting agents, binds red blood cells and platelets on the dressing's surface which provides localized clotting, independently from the normal clotting cascade. Localized clotting mitigates risk of emboli formation which can be found through the use of pro-clotting agents2.

About HemCon Medical Technologies Inc.
HemCon Medical Technologies, Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances, including Lyophilized Human Plasma and NanospiderTM technologies. HemCon is headquartered in Portland, Ore., with additional commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit

1 Data from the ChitoGauze FDA submission is available for review from HemCon Medical Technologies, Inc.
2 Studies conducted by Prof. John Whitelock, University of New South Wales, in conjunction with an Australian ARC Linkage Grant.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Nonin Medical Announces FDA Clearance for its Next-Generation Regional Oximetry System
2. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
3. Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
4. Abbott Announces Launch of Next-Generation Embolic Protection System
5. Purity Products Partners with Leading Vitamin D Expert to Create Next-Generation D3 Complex
6. Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009
7. First heart patients implanted with next-generation mechanical heart pump
8. SearchAmerica(R) Unveils Next-Generation Red Flags Rule System for Health Care
9. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
10. Parata Adopts Smart Service for Next-Generation Solutions
11. InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution
Post Your Comments:
Related Image:
Next-Generation Hemostatic Dressing Available for Military Emergencies
(Date:11/25/2015)... ... , ... Finnleo, a leader in the traditional and far-infrared sauna industry, announced ... saunas. , For traditional saunas, Finnleo is offering 20% off all ... Finnleo uses only European Grade A Nordic White Spruce from sustainably grown trees. Because ...
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to MAP ... the two groups began in 2014 with Vitalalert pledging a portion of every purchase ... in 1954 and is an international Christian-based health organization whose mission is to “advance ...
(Date:11/25/2015)... FL (PRWEB) , ... November 25, 2015 , ... ... center, is encouraging people across the country to celebrate their sobriety and show ... people to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: